Navigation Links
MGI Pharma Summarizes Data Presented at the 2007 American Society,of Clinical Oncology (ASCO) Annual Meeting

enhanced protection from chemotherapy-induced nausea and vomiting (CINV) observed with Aloxi in clinical trials.

"The data presentations at ASCO demonstrate our commitment to advancing the discovery of clinical attributes that distinguish each of the oncology products in our portfolio," said Mary Lynne Hedley, Ph.D., Executive Vice President and Chief Scientific Officer of MGI PHARMA. "We look forward to advancing the scientific understanding of our product candidates and the presentation of data at future medical meetings."

Aloxi(R) Injection

Study Results on Receptor Interactions of Aloxi Versus Other 5-HT3 Receptor Antagonists

The results of studies characterizing the molecular ligand-receptor interactions of Aloxi and the other 5-HT3 receptor antagonists, ondansetron and granisetron, were reported. Competitive versus allosteric interactions between these agents and the 5-HT(3) receptor were examined in binding experiments using each unlabeled antagonist in competition with ((3)H)-antagonist. Concentrations of ((3)H)-antagonists were representative of the probable concentrations of each antagonist at the receptor site in vivo. Based on a plot of the concentration of unlabeled antagonist needed to observe half maximal binding (IC50) as a function of ((3)H)-antagonist concentration, Aloxi demonstrated dual action suggesting competitive and allosteric interactions with the 5-HT3 receptor. In contrast, ondansetron and granisetron exhibited strictly competitive antagonism.

The Aloxi allosteric interaction with the 5-HT3 receptor indicates that it has additional inhibitory potential at the primary receptor binding site compared to the other 5-HT3 receptor antagonists studied.

Study of a Single Day Combination of Aloxi, Dexamethasone and Aprepitant in Patients Receiving Moderately Emetogenic Chemotherapy

(MEC) Regimens

The results of a study evaluating the efficacy of Aloxi in combination with dexamethasone and apr
'"/>




Page: 1 2 3 4 5 6 7 8 9 10

Related medicine technology :

1. Sygnis Pharma AG announces date for presentation of clinical results
2. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
3. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
4. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
5. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
6. Auxilium Pharmaceuticals to Present at the 2007 CEUT Emerging Growth Opportunities Conference
7. Sunesis Pharmaceuticals to Present at the C. E. Unterberg, Towbin Emerging Growth Conference
8. EPIX Pharmaceuticals to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
9. Array BioPharma to Present at the C.E Unterbeg, Towbin Emerging Growth Conference
10. AM-Pharma Announces Positive Results of Phase IIa Clinical Trial with Alkaline Phosphatase For Ulcerative Colitis
11. TransPharma Medical Announces Positive Results of Phase I Clinical Trials for Transdermal Delivery of hPTH (1-34) for Osteoporosis Treatment

Post Your Comments:
(Date:11/25/2009)...N.J.,Nov.25/PRNewswire/--TheFDAgrantedtraditionala...nucleosidereversetranscriptaseinhibitor(NNRTI).INT...reatment-experiencedadultswhoareexperiencingvirolo...erantiretroviral(ARV)agents.Thetraditionalapproval...T-1andDUET-2.INTELENCEiscurrentlymarketedintheU.S....
(Date:11/25/2009)...Md.,Nov.25/PRNewswire-USNewswire/--RemediumTechnol...thatstopsseverebleeding,wonfirstprizeand$10,000int...rityChallenge2009,companyofficialsannouncetoday. ,...rld,Remedium,steampitchedtheirinventionattheGSCSec...ss. ,, Remedium( www.remediumtechnologies.com )...
(Date:11/25/2009)...,N.J.,Nov.25/PRNewswire/--RegadoBiosciences,apriva...icaptamerswithactivecontrolagents,announcedthatDav...iperJaffray21stAnnualHealthCareConferenceattheNewY...willbegivenat1:10pm(EST)onTuesday,December1andwill...sontheleaddevelopmentprogram,theanticoagulantsyste...
Breaking Medicine Technology:U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 2U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 3U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 4Remedium Technologies Wins Most Promising Security Idea at Global Security Challenge 2009 with Blood-Clotting Foam 2Remedium Technologies Wins Most Promising Security Idea at Global Security Challenge 2009 with Blood-Clotting Foam 3Regado Biosciences to Present at the Piper Jaffray 21st Annual Health Care Conference on December 1, 2009 2MinuteClinic Offers New Rapid Pink Eye Test 3B Detects Viral Conjunctivitis Infections in Minutes 54196 1MinuteClinic Offers New Rapid Pink Eye Test 3B Detects Viral Conjunctivitis Infections in Minutes 54196 2MinuteClinic Offers New Rapid Pink Eye Test 3B Detects Viral Conjunctivitis Infections in Minutes 54196 3Foundation Radiology Group Signs Exclusive Contract With Uniontown Hospital 54193 1Foundation Radiology Group Signs Exclusive Contract With Uniontown Hospital 54193 2Photo 3A Stopain and the Arthritis Foundation Join Forces to Promote the Benefits of Staying Active 54192 1Photo 3A Stopain and the Arthritis Foundation Join Forces to Promote the Benefits of Staying Active 54192 2
...ruary 17 Sanofi Pasteur, the,vaccines division of...NY),announced today that it is sponsoring a phase ... difficile, which is among the most common causes ... America. , The trial currently conducted in t...efficacy of sanofi pasteur,s C. difficile candidat...
...en lab, will serve as international hub for collab...Feb. 16 TechTown, the Wayne State University re...he first stem cell commercialization lab in Michig...enter is the brainchild of Wayne County Executive ...,s support for the 2,500-square-foot stem cell res...
Other Medicine Technology:Sanofi Pasteur Starts a Phase II Study of a Vaccine Against Clostridium Difficile 2Sanofi Pasteur Starts a Phase II Study of a Vaccine Against Clostridium Difficile 3Sanofi Pasteur Starts a Phase II Study of a Vaccine Against Clostridium Difficile 4Sanofi Pasteur Starts a Phase II Study of a Vaccine Against Clostridium Difficile 5Wayne County Partners With TechTown to Launch Global Stem Cell 'Innovation and Commercialization Lab' 2
(Date:11/26/2009)...ers from the North Pole, Textsanta.net lets parent...a , North Pole, AK (PRWEB...cies at the North Pole Santa Claus has added SMS t...lobe informed of his Christmas progress at the Nor...tment have identified a large and growing percenta...
(Date:11/25/2009)...USNewswire/--WhenmostpeopleheartheacronymTMJ,theyt...entsthehelptheyneed.TMJstandsfortheTemporal-Mandib...nnectswithyourskull(temporalbone). ,, Themostco...hchewing,clickingorpoppingofthejaw.Butmanyothersym...hes,fatigue,sleepdisturbances,irritability,alossin...
(Date:11/25/2009)...wire/--Thanksgivingmealswillbedeliveredtoapproxima...thankstoFaithInAction/VolunteerActionforAging,apro...CANHealthPlan.Formorethan17yearstheseorganizations...sgivingmealstoseniorsinneedinLongBeach,Lakewood,Si...ies. ,, "Ourwarmholidaymealsaredeliveredtopeopl...
(Date:11/25/2009)...ncer who were treated with cisplatin-based chemoth...ological side effects and Raynaud-like phenomena, ...ccording to a new study published online November ...e . , Marianne Brydy, M.D., of the Department of...n, Norway, and colleagues conducted a cross-sectio...
(Date:11/25/2009)...atoid arthritis, could help newly diagnosed diabet...(HealthDay News) -- A drug commonly used to treat ...w also shows some promise in helping patients newl...ituximab (Rituxan), helped patients keep producing...e had destroyed some of their pancreatic beta cell...
Breaking Medicine News(10 mins):Health News:Text Messages from Santa | Santa goes GREEN by going MOBILE for The March of Dimes 2Health News:SCAN Employees and Community Volunteers to Help Deliver One Thousand Thanksgiving Meals to Homebound Seniors 2Health News:Type 1 Diabetes May Have a New Foe 2Health News:Type 1 Diabetes May Have a New Foe 3
... HCA announces the,following Webcast:, What: ... Where: http://www.videonewswire.com/event.as...Simply log on to the web at the address...s and operates approximately 169 hospitals and app...
...nc. (Nasdaq:,EVVV) today announced that Robert Pal...scheduled to present at the Bank of America 2008 H...:00 p.m. PT (7:00 p.m. ET and 6:00,p.m. CT). The B...ection of the ev3 Web site,at http://www.ev3.net ...
...00 doctors,have given 20 million free books to Ame... to Reach Out and Read. Partnering with doctors to...o their parents at check-ups, Reach,Out and Read n...(Photo: http://www.newscom.com/cgi-bin/prnh/20080...
...n Overnight Trip Than Having Own Toothbrush, PRIN...a relationship do men and women feel comfortable s...had to choose between not brushing,their teeth for...ppropriate alternative use for their old-fashioned...
...odborne diseases cause an estimated 76 million ill...iated with restaurant meals. More than 70 billion ... U.S., accounting for 47% of total food expenditur...in the June 2008 issue of the American Journal of ...
... an 89% initial success,rate in arresting or eradi...ville-based treatment is being offered to the publ...tion Director of Research Dr. Stephen,Cantrell, ga...t melanoma, as well as pancreatic and some of the ...
Other Medicine News:Health News:20 Million Kids' Books Distributed, 25% of U.S. Children in Poverty Getting Books, 50,000 Doctors Trained: Three Key Milestones for Reach Out and Read 2Health News:Crest(R) SPINBRUSH(R) Oral Hygiene Survey Reveals "Nothin' but the Tooth" 2Health News:Crest(R) SPINBRUSH(R) Oral Hygiene Survey Reveals "Nothin' but the Tooth" 3Health News:Crest(R) SPINBRUSH(R) Oral Hygiene Survey Reveals "Nothin' but the Tooth" 4Health News:Restaurant inspections -- public perceptions vs. reality 2Health News:New Treatment Offers Hope for Beating Aggressive Cancers 2
Cold Shoulder™ Therapy Wrap
Comfor™ Clavicle Brace - Buckle Closure
...low back pain, they want relief right away. The Qu... providing powerful compression for immediate pain...d directly to men's or women's clothing sizes, the...hile simplifying the fitting process.,The per...
...ive immobilization of the cervical and upper thora...ll tolerated by patients. Research has shown subst...a stand-alone cervical collar, to a two-post devic...reasons, the Aspen® CTO system offers the grea...
Medicine Products: